The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes and clinical markers associated with benefit from ipilimumab (Ipi) in patients with advanced melanoma: A retrospective single-institution study.
Zachary Franklin Zimmerman
No relevant relationships to disclose
Barry Storer
No relevant relationships to disclose
Amandeep Godara
No relevant relationships to disclose
John A. Thompson
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb
Kim Allyson Margolin
Honoraria - Genentech
Research Funding - Altor BioScience; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Merck
Scott S. Tykodi
Research Funding - Bristol-Myers Squibb
Jason K. Rockhill
No relevant relationships to disclose
Sylvia Mina Lee
No relevant relationships to disclose
Anna Brown
No relevant relationships to disclose
Amila Patel
No relevant relationships to disclose
Jon Smith
Honoraria - Bristol-Myers Squibb
Shailender Bhatia
Research Funding - Bristol-Myers Squibb